PT - JOURNAL ARTICLE AU - d’Alessandro, Vincenzo AU - Balasco, Nicole AU - Ferrara, Pietro AU - Vitagliano, Luigi TI - The temporal correlation between positive testing and death in Italy: from the first phase to the later evolution of the COVID-19 pandemic AID - 10.1101/2021.07.14.21260505 DP - 2021 Jan 01 TA - medRxiv PG - 2021.07.14.21260505 4099 - http://medrxiv.org/content/early/2021/07/15/2021.07.14.21260505.short 4100 - http://medrxiv.org/content/early/2021/07/15/2021.07.14.21260505.full AB - After the global spread of the novel coronavirus disease 2019 (COVID-19), research has concentrated its efforts on several aspects of the epidemiological burden of pandemic. In this frame, the presented study follows a previous analysis of the temporal link between cases and deaths during the first epidemic wave (Phase 1) in Italy (March-June 2020). We here analyze the COVID-19 epidemic in the time span from March 2020 to June 2021. The elaboration of the curves of cases and deaths allows identifying the temporal shift between the positive testing and the fatal event, which corresponds to one week from W2 to W33, two weeks from W34 to W41, and three weeks from W42 to W67. Based on this finding, we calculate the Weekly Lethality Rate (WLR). The WLR was grossly overestimated (~13.5%) in Phase 1, while a mean value of 2.6% was observed in most of Phase 2 (starting from October 2020), with a drop to 1.4% in the last investigated weeks. Overall, these findings offer an interesting insight into the magnitude and time evolution of the lethality burden attributable to COVID-19 during the entire pandemic period in Italy. In particular, the analysis highlighted the impact of the effectiveness of public health and social measures, of changes in disease management, and of preventive strategies over time.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe present activities have been performed in the framework of project 'RicErCa e sviluppO VERsus COVID19 in Campania RECOVER-COVID19' funded by the Campania RegionAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study did not involve participants and information were gathered from freely accessible public databases, and data were analyzed in aggregated form and without any identifier. Therefore, no ethical approval was required for this research. The analyses adhere to the Guidelines for Accurate and Transparent Health Estimates Reporting (GATHER).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data are available